Thomas Amort
Rediff.com » News » Thomas Amort
News for Thomas Amort
Web results for Thomas Amort
Onex fails to find buyer for Carestream Health
By Soyoung Kim and Greg Roumeliotis NEW YORK (Reuters) - Onex Corp (OCX.TO: Quote, Profile, Research) has called off its auction of medical imaging... ...
http://in.reuters.com/article/2013/05/17/us-carestream-onex-idINBRE94G0U920130517Novartis wins GBCHealth Business Action on Health Award for social ventures initiative
Novartis International AG / . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this... ...
http://www.andhranews.net/Business/2013/Novartis-wins-GBCHealth-Business-Action-Health-21788.htmSwedish drug maker Recipharm looks to list or sell stake-source
STOCKHOLM (Reuters) - Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing on the... ...
http://in.reuters.com/article/2013/05/16/us-recipharm-ipo-idINBRE94F0RF20130516?feedType=RSS&feedName=health FFO per unit up 13.6% for the three month period..
Boardwalk REIT Announces Solid First Quarter Financial Results: FFO per unit up 13.6% for the three month period ended March ... Boardwalk Equities... ...
http://in.advfn.com/p.php?pid=nmona&article=57592308Novartis drug Ilaris approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
Novartis International AG /Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of... ...
http://andhranews.net/Business/2013/Novartis-drug-Ilaris-approved-FDA-treat-20503.htmTop Coverage News
© 2013 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Careers - Feedback | Terms of use | India Abroad weekly